Identification of H-Ras-Specific motif for the activation of invasive signaling program in human breast epithelial cells

Neoplasia

Volumn 13, Issue 2, 2011, Pages 98-107

  Yong, Hae Young ^a   Hwang, Jin Sun ^a   Son, Hwajin ^a   Park, Hae In ^b   Oh, Eok Soo ^b   Kim, Hyun Hwi ^c   Kim, Do Kyun ^d   Choi, Wahn Soo ^d   Lee, Bong Jin ^c   Kim, Hyeong Reh Choi ^e   Moon, Aree ^a  

^a Duksung Women's University   (South Korea)

^b Ewha Womans University   (South Korea)

^c Seoul National University   (South Korea)

^d Konkuk University   (South Korea)

^e WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYSTEINE; GUANINE NUCLEOTIDE BINDING PROTEIN; H RAS PROTEIN; PROLINE; PROTEIN N RAS; UNCLASSIFIED DRUG;

AMINO ACID SEQUENCE; ARTICLE; BREAST EPITHELIUM; CARBOXY TERMINAL SEQUENCE; CELL INVASION; CELL MIGRATION; CONTROLLED STUDY; EPITHELIUM CELL; HUMAN; HUMAN CELL; PALMITOYLATION; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN MOTIF; SIGNAL TRANSDUCTION;

EID: 79951495657     PISSN: 15228002     EISSN: 14765586     Source Type: Journal    
DOI: 10.1593/neo.101088     Document Type: Article

References (43)

1. Boguski MS and McCormick F (1993). Proteins regulating Ras and its relatives. Nature 366, 643-654.
2. Clair T, Miller WR, and Cho-Chung YS (1987). Prognostic significance of theexpression of a ras protein with a molecular weight of 21,000 by human breastcancer. Cancer Res 47, 5290-5293.
3. Clark GJ and Der CJ (1995). Aberrant function of the Ras signal transductionpathway in human breast cancer. Breast Cancer Res Treat 35, 133-144.
4. Franks LM and Teich NM (1997). Cellular and Molecular Biology of Cancer. Oxford University Press, New York, NY.
5. Moon A, Kim MS, Kim TG, Kim SH, Kim HE, Chen YQ, and Kim HR (2000). H-ras, but not N-ras, induces an invasive phenotype in human breastepithelial cells: a role for MMP-2 in the H-ras-induced invasive phenotype. Int J Cancer 85, 176-181.
6. Kim MS, Lee EJ, Kim HR, and Moon A (2003). p38 kinase is a key signalingmolecule for H-Ras-induced cell motility and invasive phenotype in humanbreast epithelial cells. Cancer Res 63, 5454-5461.
7. Shin I, Kim S, Song H, Kim HR, and Moon A (2005). H-Ras-specific activationof Rac-MKK3/6-p38 pathway: its critical role in invasion and migration of breast epithelial cells. J Biol Chem 280, 14675-14683.
8. Song H, Ki SH, Kim SG, and Moon A (2006). Activating transcription factor 2mediates matrix metalloproteinase-2 transcriptional activation induced by p38 inbreast epithelial cells. Cancer Res 66, 10487-10496.
9. Barbacid M (1987). Ras genes. Annu Rev Biochem 56, 779-827.
10. McCormick F (1993). Signal transduction. How receptors turn Ras on. Nature 363, 15-16.
11. Milburn MV, Tong L, deVos AM, Brünger A, Yamaizumi Z, Nishimura S, and Kim SH (1990). Molecular switch for signal transduction: structural differencesbetween active and inactive forms of protooncogenic ras proteins. Science 247, 939-945.
12. Gorfe AA, Babakhani A, and McCammon JA (2007). H-Ras protein in a bilayer:interaction and structure perturbation. J Am Chem Soc 129, 12280-12286.
13. Hancock JF (2003). Ras proteins: different signals from different locations. Nat Rev Mol Cell Biol 4, 373-384.
14. Rowinsky EK, Windle JJ, and Von Hoff DD (1999). Ras protein farnesyltransferase:a strategic target for anticancer therapeutic development. J Clin Oncol 17, 3631-3652.
15. Willumsen BM, Christensen A, Hubbert NL, Papageorge AG, and Lowy D (1984). The p21 ras C-terminus is required for transformation and membraneassociation. Nature 310, 583-586.
16. Hancock JF, Magee AI, Childs JE, and Marshall CJ (1989). All ras proteins arepolyisoprenylated but only some are palmitoylated. Cell 57, 1167-1177.
17. Roberts PJ, Mitin N, Keller PJ, Chenette EJ, Madigan JP, Currin RO, Cox AD, Wilson O, Kirschmeier P, and Der CJ (2008). Rho family GTPase modificationand dependence on CAAX motif-signaled posttranslational modification. J Biol Chem 283, 25150-25163.
18. Wright LP and Philips MR (2006). CAAX modification and membrane targetingof Ras. J Lipid Res 47, 883-891.
19. Prior IA, Harding A, Yan J, Sluimer J, Parton RG, and Hancock JF (2001). GTP-dependent segregation of H-ras from lipid rafts is required for biologicalactivity. Nat Cell Biol 3, 368-375.
20. Roy S, Plowman S, Rotblat B, Prior IA, Muncke C, Grainger S, Parton RG, Henis YI, Kloog Y, and Hancock JF (2005). Individual palmitoyl residues servedistinct roles in H-ras trafficking, microlocalization, and signaling. Mol Cell Biol 25, 6722-6733.
21. Draper JM and Smith CD (2009). Palmitoyl acyltransferase assays and inhibitors [review]. Mol Membr Biol 26, 5-13.
22. Hancock JF, Peterson H, and Marshall CJ (1990). A polybasic domain orpalmitoylation is required in addition to the CAAX motif to localize p21ras to theplasma membrane. Cell 63, 133-139.
23. Hancock JF, Cadwallader K, Paterson H, and Marshall CJ (1991). A CAAX ora CAAX motif and a second signal are sufficient for plasma membrane targetingof ras proteins. EMBO J 10, 4033-4039.
24. Wang W, Chen JX, Liao R, Deng Q, Zhou JJ, Huang S, and Sun P (2002). Sequentialactivation of the MEK-extracellular signal-regulated kinase and MKK3/6-p38 mitogen-activated protein kinase pathways mediates oncogenic ras-inducedpremature senescence. Mol Cell Biol 22, 3389-3403.
25. Bihani T, Mason DX, Jackson TJ, Chen SC, Boettner B, and Lin AW (2004). Differential oncogenic Ras signaling and senescence in tumor cells. Cell Cycle 3, 1201-1207.
26. Reddy HK, Graña X, Dhanasekaran DN, Litvin J, and Reddy EP (2010). Requirementof Cdk4 for v-H-ras Induced breast tumorigenesis and activation of thev-ras-induced senescence program by the R24C mutation. Genes Cancer 1, 69-80.
27. Moon A, Yong HY, Song JI, Cukovic D, Salagrama S, Kaplan D, Putt D, Kim H, Dombkowski A, and Kim HR (2008). Global gene expression profiling unveils S100A8/A9 as candidate markers in H-ras-mediated human breast epithelial cellinvasion. Mol Cancer Res 6, 1544-1553.
28. Casey PJ and Seabra MC (1996). Protein prenyltransferases. J Biol Chem 271, 5289-5292.
29. Ishihara N, Yamashina S, Sakaguchi M, Mihara K, and Omura T (1995). Malfoldedcytochrome P-450(M1) localized in unusual membrane structures of theendoplasmic reticulum in cultured animal cells. J Biochem 118, 397-404.
30. Yamazaki S, Sato K, Suhara K, Sakaguchi M, Mihara K, and Omura T (1993). Importance of the proline-rich region following signal-anchor sequence in theformation of correct conformation of microsomal cytochrome P-450s. J Biochem 114, 652-657.
31. Wester MR, Johnson EF, Marques-Soares C, Dijols S, Dansette PM, Mansuy D, and Stout CD (2003). Structure of mammalian cytochrome P450 2C5 complexedwith diclofenac at 2.1 Å resolution: evidence for an induced fit modelof substrate binding. Biochemistry 42, 9335-9345.
32. Kemper B (2004). Structural basis for the role in protein folding of conservedproline-rich regions in cytochromes P450. Toxicol Appl Pharmacol 199, 305-315.
33. Jaumot M, Yan J, Clyde-Smith J, Sluimer J, and Hancock JF (2002). The linkerdomain of the Ha-Ras hypervariable region regulates interactions with exchangefactors, Raf-1 and phosphoinositide 3-kinase. J Biol Chem 277, 272-278.
34. Laude AJ and Prior IA (2008). Palmitoylation and localisation of RAS isoforms aremodulated by the hypervariable linker domain. J Cell Sci 121(pt 4), 421-427.
35. Jaumot M and Hancock JF (2001). Protein phosphatases 1 and 2A promote Raf-1 activation by regulating 14-3-3 interactions. Oncogene 20, 3949-3958.
36. Hansen M, Rusyn EV, Hughes PE, Ginsberg MH, Cox AD, and Willumsen BM (2002). R-Ras C-terminal sequences are sufficient to confer R-Ras specificity to H-Ras. Oncogene 21, 4448-4461.
37. Hansen M, Prior IA, Hughes PE, Oertli B, Chou FL, Willumsen BM, Hancock JF, and Ginsberg MH (2003). C-terminal sequences in R-Ras are involved in integrinregulation and in plasma membrane microdomain distribution. Biochem Biophys Res Commun 311, 829-838.
38. Jeong HW, Nam JO, and Kim IS (2005). The COOH-terminal end of R-Rasalters the motility and morphology of breast epithelial cells through Rho/Rhokinase. Cancer Res 65, 507-515.
39. Omerovic J, Laude AJ, and Prior IA (2007). Ras proteins: paradigms for compartmentalisedand isoform-specific signaling. Cell Mol Life Sci 64, 2575-2589.
40. Holt MR and Koffer A (2001). Cell motility: proline-rich proteins promoteprotrusions. Trends Cell Biol 11, 38-46.
41. Stein U, Walther W, Arlt F, Schwabe H, Smith J, Fichtner I, Birchmeier W, and Schlag PM (2009). MACC1, a newly identified key regulator of HGF-METsignaling, predicts colon cancer metastasis. Nat Med 15, 59-67.
42. Wang B, Zou JX, Ek-Rylander B, and Ruoslahti E (2000). R-Ras contains aproline-rich site that binds to SH3 domains and is required for integrin activationby R-Ras. J Biol Chem 275, 5222-5227.
43. Pai EF, Kabsch W, Krengel U, Holmes KC, John J, and Wittinghofer A (1989). Structure of the guanine-nucleotide-binding domain of the Ha-ras oncogeneproduct p21 in the triphosphate conformation. Nature 341, 209-214.